4372 |
Who Should Do Left Main and How? |
Mamas Mamas |
Apr. 20. 23 |
4371 |
Practice Changes of LM & MVD Revascularization 2023 |
Fahim Haider Jafary |
Apr. 20. 23 |
4370 |
Surgery is Still Standard |
David Paul Taggart |
Apr. 20. 23 |
4369 |
Medical Therapy is Enough |
Sripal Bangalore |
Apr. 20. 23 |
4368 |
Insight from All Data for Triple Vessel Disease |
Seung-Jung Park |
Apr. 20. 23 |
4367 |
Insight from All Data of Left Main Revascularization (MAINCOMPARE, SYNTAX, PRECOMBAT, NOBLE, EXCEL) |
Duk-Woo Park |
Apr. 20. 23 |
4366 |
LM & MVD Revascularization 2023: Guidelines and Beyond |
Sripal Bangalore |
Apr. 20. 23 |
4365 |
Up-to-date TAVR Data from AMC (TP TAVR, ADAPT-TAVR, ASAN TAVR Registry) |
Do-Yoon Kang |
Apr. 20. 23 |
4364 |
Ultra-Minimalist TAVR - Strategies for a Quick Procedure and Short Hospital Stay |
James Flaherty |
Apr. 20. 23 |
4363 |
Coronary Protection in Patients Undergoing TAVI at High Risk of Coronary Occlusion |
Tullio Palmerini |
Apr. 20. 23 |